(FDA Approved De Novo) Validating Impact on Childhood Subclinical Anxiety & Depression
Read More
April 28, 2025
Collaboration with Claudia Louise Walker Foundation aims to support mental health, addressing Anxiety&Depression, and separately, reducing suicide risks among children.
Read More
December 7, 2024
(FDA Approved De Novo) Validating Impact on Childhood Subclinical Anxiety & Depression
Read More
September 20, 2024
Explore Dr. Mooves A&D’s exciting new features, designed to enhance cognitive skill-building and reward children’s engagement.
Read More
September 1, 2024
New field study launched by Dr. Mooves A&D to measure the app’s impact on childhood subclinical anxiety, depression, and emotional resilience.
Read More
March 26, 2024
Dr. Mooves A&D secures two groundbreaking patents, advancing innovative digital tools for children’s cognitive development and mental health.
Read More
January 30, 2024
Dr. Mooves A&D partners with HITLab to expand digital solutions that empower children to manage anxiety and depression.
Read More